Product Type: Market Research Report
Published by: Cutting Edge Information
Published: March 2008
Product Code: R465-75Description Increase the effectiveness of your LCM Strategies:
With pipelines diminishing and generics becoming more aggressive, pharmaceutical companies must maximize their brands’ value and time on the market. Strategic and well-orchestrated lifecycle management efforts are crucial to maintaining a brand’s long-term health.
Cutting Edge Information’s report A Guidebook to Pharma Brand Optimization analyzes the inner-workings of lifecycle management strategy, development and implementation processes. This study provides companies with the tools to improve their lifecycle management efforts by exploring top pharmaceutical companies’ LCM structures, processes, best practices, strategies and tactical approaches. The report makes its case with metrics and techniques for launching effective lifecycle management efforts.
Structure and Funding - Learn how pharmaceutical companies are establishing dedicated lifecycle management teams to spearhead efforts. Benchmark functional involvement and funding support.
LCM Processes, Challenges and Measurements - Examine top companies’ lifecycle management LCM objectives and goals. Analyze the processes companies take to launch comprehensive LCM strategies as well as many common challenges they must overcome to be successful.
Drug Time Periods - Explore the strategies that companies should be considering at three major points in a drug’s lifecycle - pre-launch, peak and mature time periods. Within each time period are LCM tactic profiles that analyze the individual tactics in detail including resources, timeframes and real-world case studies.
Individual LCM Brand Profiles - Uncover the resource support that individual brands receive for their lifecycle management efforts annually during pre-launch, peak and mature time periods.
Use this study to win additional resource support for your lifecycle management efforts. Examine the brand profiles and case studies to learn from real-world company examples.Table of Contents - The following is a list of metrics included in A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy. While this list is not inclusive of all the data in the report, it summarizes the main categories and types of data included in each chapter.
- Chapter 1:
- Companies’ LCM Structures
- Dedicated Lifecycle Management Team
- Dedicated Lifecycle Management Team Reports to Which Department
- Departments Responsible for LCM when No Dedicated Team Exists
- Company F’s LCM Structure
- Title of Those Responsible for Spearheading LCM
- Other Functions Involved in LCM During Various Time Periods
- LCM Budgets Tied to Individual Brands
- Funding of LCM Budgets
- Lifecycle Management Ratings
- Important Factors to Have a Successful LCM Effort
- Areas with Greatest Room for Improvement
- Importance of Criteria in Assessing LCM Tactics
- LCM Success Measurements
- Chapter 2:
- Pre-Launch LCM Tactical Timeline
- Pre-Launch LCM Strategy Investment Levels
- Average Time to Implement Pre-Launch LCM Strategies
- Pre-Launch LCM Strategy Time to Implement vs. Return on Investment
- Pre-Launch LCM Strategy Return on Investment
- There are five LCM tactics examined in this chapter, including divestitures, new formulations/delivery systems, strategic alliances/licensing, publications strategy and contracting with large volume purchasers. Within each LCM tactic profile there are the following graphics:
- Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
- Planning for Tactic Begins
- Implementation for Tactic Begins
- Effectiveness of LCM Tactic
- Chapter 3:
- Peak (Launch until two years prior to US patent expiration) LCM Tactical Timeline
- Peak LCM Strategy Investment Levels
- Average Time to Implement Peak LCM Strategies
- Peak LCM Strategy Time to Implement vs. Return on Investment
- Peak LCM Strategy Return on Investment
- There are six LCM tactics examined in this chapter: strategic pricing, new dosing frequency, new dosing strength, new indication, CRM/disease management, market repositioning and repurposing. Within each LCM tactic profile there are the following graphics:
- Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
- Planning for Tactic Begins
- Implementation for Tactic Begins
- Effectiveness of LCM Tactic
- Chapter 4:
- Mature (Two years prior to US patent expiration and beyond) LCM Tactical Timeline
- Mature LCM Strategy Investment Levels
- Average Time to Implement Mature LCM Strategies
- Mature LCM Strategy Time to Implement vs. Return on Investment
- Mature LCM Strategy Return on Investment
- There are six LCM tactics examined in this chapter including: pediatric indications, new combinations, next generation product, patent litigation, branded generics, Rx-to-OTC and removal from market. Within each LCM tactic profile there are the following graphics:
- Tactic Dashboard: Implementation Timeline, Return on Investment, Development Time, Average Investment, Industry Case Studies
- Planning for Tactic Begins
- Implementation for Tactic Begins
- Effectiveness of LCM Tactic
- Chapter 5:
- There are seven individual brand LCM profiles, most of which contain the following metrics and graphics.
- Brand Overview: Peak Sales, Therapeutic Area, Company Size, Brand Erosion, Number of Years of Patent Protection on US Market
- Competitive Outlook: Number of Generic and Branded Competitors
- Greatest Threats to Brand
- LCM Tactical Approach
- LCM Tactic Timelines: When Planning for Tactic Begins
- Annual LCM Strategy Investments
- LCM Strategy Annual Investments by Time Period
- LCM Headcount Support
- Percentage of Brand’s Marketing Budget Allocated to LCM
- LCM Strategy Investments, Returns and Returns on Investment Percentages
- LCM Strategies’ Average Returns Per Dollar Invested
|
|
